In 1999, mutations in the MECP2 gene were identified as the primary cause of Rett syndrome. MECP2 mutations can be found in 70% to 80% of all clinically defined Rett syndrome cases; in classic Rett syndrome, this frequency is even higher. In most cases, missense and nonsense mutations affecting functionally important domains can be found. Additionally, a hot spot for small deletions has been defined, and several gross rearrangements have also been described. Among female individuals with Rett syndrome, the spectrum of clinical phenotypes is broad, but most fulfill the diagnostic criteria. In contrast, male individuals with mutations in the MECP2 gene are rare, and only a minority have clinical symptoms resembling Rett syndrome. (J Child Neurol 2005;20:732—736).
Get full access to this article
View all access options for this article.
References
1.
Sirianni N., Naidu S., Pereira J., et al: Rett syndrome: Confirmation of X-linked dominant inheritance, and localization of the gene to Xq28. Am J Hum Genet1998;63:1552—1558.
2.
Amir RE, Van den Veyver IB, Wan M., et al: Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet1999 ;23:185—188.
3.
Amir R., Dahle EJ, Toriolo D., et al: Candidate gene analysis in Rett syndrome and the identification of 21 SNPs in Xq. Am J Med Genet2000;90:69—71.
4.
Adler DA, Quaderi NA, Brown SD, et al: The X-linked methylated DNA binding protein, MECP2, is subject to X inactivation in the mouse. Mamm Genome1995;6:491—492.
5.
D'Esposito M. , Quaderi NA, Ciccodicola A., et al: Isolation, physical mapping, and Northern analysis of the X-linked human gene encoding methyl CpG-binding protein, MECP2 . Mamm Genome1996;7:533—535.
6.
Mnatzakanian GN, Lohi H., Munteanu I., et al: A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome. Nat Genet2004;36:339—341.
7.
Kriaucionis S., Bird A.: The major form of MECP2 has a novel N-terminus generated by alternative splicing. Nucleic Acids Res2004;32:1818—1823.
8.
Lewis JD, Meehan RR, Henzel WJ, et al: Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell1992;69:905—914.
9.
Nan X., Meehan RR, Bird A.: Dissection of the methyl-CpG binding domain from the chromosomal protein MECP2 . Nucleic Acids Res1993;21:4886—4892.
10.
Nan X., Campoy FJ, Bird A.: MECP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell1997;88:471—481.
11.
Chandler SP , Guschin D., Landsberger N., et al: The methyl-CpG binding transcriptional repressor MECP2 stably associates with nucleosomal DNA. Biochemistry1999;38:7008—7018.
12.
Evans JC, Archer HL, Whatley SD, et al: Variation in exon 1 coding region and promoter of MECP2 in Rett syndrome and controls. Eur J Hum Genet2005 ;13:124—126.
13.
Shibayama A. , Cook EH Jr, Feng J., et al: MECP2 structural and 3'UTR variants in schizophrenia, autism and other psychiatric diseases: A possible association with autism. Am J Med Genet2004;128B:50—53.
14.
Beyer KS, Blasi F., Bacchelli E., et al: Mutation analysis of the coding sequence of the MECP2 gene in infantile autism. Hum Genet2002;111:305—309.
15.
Buyse IM, Fang P., Hoon KT, et al: Diagnostic testing for Rett syndrome by DHPLC and direct sequencing analysis of the MECP2 gene: Identification of several novel mutations and polymorphisms. Am J Hum Genet2000;67:1428—1436.
16.
Thistlethwaite WA, Moses LM, Hoffbuhr KC, et al: Rapid genotyping of common MECP2 mutations with an electronic DNA microchip using serial differential hybridization. J Mol Diagn2003;5:121—126.
17.
Erlandson A. , Samuelsson L., Hagberg B., et al: Multiplex ligation-dependent probe amplification (MLPA) detects large deletions in the MECP2 gene of Swedish Rett syndrome patients. Genet Test2003;7:329—332.
18.
Laccone F., Junemann I., Whatley S., et al: Large deletions of the MECP2 gene detected by gene dosage analysis in patients with Rett syndrome. Hum Mutat2004;23:234—244.
19.
Bourdon V., Philippe C., Grandemenge A., et al: Deletion screening by fluorescence in situ hybridization in Rett syndrome patients. Ann Genet2001;44:191—194.
20.
Ariani F., Mari F., Pescucci C., et al: Real-time quantitative PCR as a routine method for screening large rearrangements in Rett syndrome: Report of one case of MECP2 deletion and one case of MECP2 duplication. Hum Mutat2004;24:172—177.
21.
Miltenberger-Miltenyi G., Laccone F.: Mutations and polymorphisms in the human methyl CpG-binding protein MECP2. Hum Mutat2003;22:107—115.
22.
Lee SS, Wan M., Francke U.: Spectrum of MECP2 mutations in Rett syndrome. Brain Dev2001;23(Suppl 1):S138—S143.
23.
Yusufzai TM , Wolffe AP: Functional consequences of Rett syndrome mutations on human MECP2. Nucleic Acids Res2000;28:4172—4179.
24.
Huppke P., Held M., Laccone F., et al: The spectrum of phenotypes in females with Rett syndrome. Brain Dev2003;25:346—351.
25.
Oexle K., Thamm-Mucke B., Mayer T., et al: Macrocephalic mental retardation associated with a novel C-terminal MECP2 frameshift deletion. Eur J Pediatr2004 .
26.
Lobo-Menendez F., Sossey-Alaoui K., Bell JM, et al: Absence of MECP2 mutations in patients from the South Carolina Autism Project. Am J Med Genet B Neuropsychiatr Genet2003; 117:97-101.
27.
Watson P., Black G., Ramsden S., et al: Angelman syndrome phenotype associated with mutations in MECP2, a gene encoding a methyl CpG binding protein. J Med Genet2001;38:224—228.
28.
Hitchins MP , Rickard S., Dhalla F., et al: Investigation of UBE3A and MECP2 in Angelman syndrome (AS) and patients with features of AS. Am J Med Genet A2004;125:167—172.
29.
Trappe R., Laccone F., Cobilanschi J., et al: MECP2 mutations in sporadic cases of Rett syndrome are almost exclusively of paternal origin. Am J Hum Genet2001;68:1093—1101.
30.
Hoffbuhr K. , Devaney JM, LaFleur B., et al: MECP2 mutations in children with and without the phenotype of Rett syndrome. Neurology2001;56:1486—1495.
31.
Villard L., Kpebe A., Cardoso C., et al: Two affected boys in a Rett syndrome family: Clinical and molecular findings. Neurology2000;55:1188—1193.
32.
Wan M., Lee SS, Zhang X., et al: Rett syndrome and beyond: Recurrent spontaneous and familial MECP2 mutations at CpG hotspots. Am J Hum Genet1999;65:1520—1529.
33.
Zeev BB, Yaron Y., Schanen NC, et al: Rett syndrome: Clinical manifestations in males with MECP2 mutations . J Child Neurol2002;17:20—24.
34.
Lynch SA, Whatley SD, Ramesh V., et al: Sporadic case of fatal encephalopathy with neonatal onset associated with a T158M missense mutation in MECP2. Arch Dis Child Fetal Neonatal Ed2003;88:F250—F252.
35.
Leonard H., Silberstein J., Falk R., et al: Occurrence of Rett syndrome in boys. J Child Neurol2001;16:333—338.
36.
Clayton-Smith J., Watson P., Ramsden S., et al: Somatic mutation in MECP2 as a non-fatal neurodevelopmental disorder in males. Lancet2000;356:830—832.
37.
Schwartzman JS , Bernardino A., Nishimura A., et al: Rett syndrome in a boy with a 47,XXY karyotype confirmed by a rare mutation in the MECP2 gene. Neuropediatrics2001;32:162—164.
38.
Kleefstra T., Yntema HG, Nillesen WM, et al: MECP2 analysis in mentally retarded patients: Implications for routine DNA diagnostics. Eur J Hum Genet2004 ; 12:24-28.
39.
Couvert P., Bienvenu T., Aquaviva C., et al: MECP2 is highly mutated in X-linked mental retardation. Hum Mol Genet2001; 10:941—946.
40.
Imessaoudene B., Bonnefont JP, Royer G., et al: MECP2 mutation in non-fatal, non-progressive encephalopathy in a male. J Med Genet2001 ;38:171—174.
41.
Klauck SM, Lindsay S., Beyer KS, et al: A mutation hot spot for nonspecific X-linked mental retardation in the MECP2 gene causes the PPM-X syndrome. Am J Hum Genet2002; 70:1034-1037.
42.
Orrico A., Lam C., Galli L., et al: MECP2 mutation in male patients with non-specific X-linked mental retardation. FEBS Lett2000;481:285—288.
43.
Winnepenninckx B., Errijgers V., Hayez-Delatte F., et al: Identification of a family with nonspecific mental retardation (MRX79) with the A140V mutation in the MECP2 gene: Is there a need for routine screening?Hum Mutat2002 ;20:249—252.
44.
Yntema HG, Oudakker AR, Kleefstra T., et al: In-frame deletion in MECP2 causes mild nonspecific mental retardation . Am J Med Genet2002;107:81—83.
45.
Gomot M., Gendrot C., Verloes A., et al: MECP2 gene mutations in non-syndromic X-linked mental retardation: Phenotype-genotype correlation. Am J Med Genet A2003;123:129—139.
46.
Moog U., Smeets EE, van Roozendaal KE, et al: Neurodevelopmental disorders in males related to the gene causing Rett syndrome in females (MECP2). Eur J PaediatrNeurol2003; 7:5—12.
47.
Huppke P., Kohler K., Laccone F., et al: Indication for genetic testing: A checklist for Rett syndrome . J Pediatr2003; 142:332—335.
